Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 13, 2019 Off

New data from Janssen presented at the Annual European Congress of Rheumatology (EULAR 2019) shows sustained clinical benefit and reduction in severe flares with Stelara® (ustekinumab) in patients with systemic lupus erythematosus (SLE)

By BusinessWire

MADRID–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson presented this week results of two analyses from a Phase 2…

June 13, 2019 Off

Hemophilia A Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hemophilia A Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Hemophilia A…

June 13, 2019 Off

Uveitis Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Uveitis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Uveitis Pipeline Highlights…

June 13, 2019 Off

Dry Age-Related Macular Degeneration Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Dry Age-Related Macular Degeneration Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering.…

June 13, 2019 Off

Opioid Addiction Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Opioid Addiction Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Opioid Addiction…

June 13, 2019 Off

Septic Shock Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Septic Shock Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Septic Shock…

June 13, 2019 Off

Autism Spectrum Disorders Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Autism Spectrum Disorders Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Autism…

June 13, 2019 Off

Acute Pain Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Acute Pain Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Acute Pain…

June 13, 2019 Off

Attention Deficit Hyperactivity Disorder Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Attention Deficit Hyperactivity Disorder Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering.…

June 13, 2019 Off

Janssen presents new real-world evidence at the Annual European Congress of Rheumatology (EULAR 2019) which suggests that effective PsA treatment should target more than skin and joints

By BusinessWire

MADRID–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data this week from PsABio – its ongoing, real-world…

Posts pagination

Previous 1 … 3,098 3,099 3,100 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine